Stunning new £35m building could signal important change for Liverpool liverpoolecho.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from liverpoolecho.co.uk Daily Mail and Mail on Sunday newspapers.
Mike Chapman with wife Jo and their four grandchildren at Mike s 69th birthday A NEW medical technique targeting hard to reach tumours is being trialled at Clatterbridge Cancer Centre. Interventional Radiology is enabling injection of treatments directly into the liver of patient Mike Chapman, who is taking part in the research. Retired chartered engineer Mike is being given a hormone therapy designed to attack his liver cancer cells but leave normal ones intact, shrinking tumours and killing any other cancer cells in his body. The 69-year-old was successfully treated for a rare eye cancer in 2014 but in January last year doctors told him it had spread to his liver.
Speakers confirmed include:
Tony Reeves, chief executive, Liverpool City Council, who joined in August 2018 and is working to improve processes following the recent Caller report into the council’s operations
pre-recorded interview
Iain Finlayson, estate director, Liverpool ONE, who works alongside Grosvenor Britain & Ireland to lead the estate team in its activity and communications, whilst overseeing liaison with wider Liverpool community organisations and stakeholders
Bill Addy, CEO, Liverpool BID Company, whose districts cover 120 acres of Liverpool and are home to 1,500 businesses employing more than 70,000 people
Nicola Rigby, principal, Avison Young, who is also the company’s North-West development and regeneration lead, supporting the continuing economic revival of the region
Share this article
Share this article
The successful British scale-up has attracted senior figures in international business development, pharmaceutical commercial strategy and nutrition innovation in San Diego, Cambridge Massachusetts, and New York to help shape the next phase of its worldwide growth
CAMBRIDGE, United Kingdom, May 11, 2021 /PRNewswire/ Eagle Genomics, a pioneer in applying network science to biology, has announced the appointment of three prestigious US-based advisory board members to its global panel, to help shape the next phase of its growth internationally. The move comes as the world s biggest brands in food, personal care and agriculture biotechnology (AgBio) look to play their part in addressing real-world challenges with innovative, sustainable, next-generation products that work symbiotically with the microbiome.
(0)
The British success story continues apace as the biggest names in food, cosmetics, personal care & agritech globally look to confirm the positive biological impact of next-generation products, and play their part in solving real-world challenges capitalising on the worldwide microbiome megatrend
CAMBRIDGE, England, May 4, 2021 /PRNewswire/ Eagle Genomics, a British pioneer in applying network science to biology, has announced the opening of a formal new operation in India - within the innovation hub of Laxmi Cyber City in Hyderabad - as the bio revolution continues to transform the global economy.
Eagle Genomics has been hitting the headlines over the last year, with its ground-breaking approach to networking microbiome science - with its